On July 5, 2023, the Government of Saskatchewan issued new regulations to update the existing newborn screening process under The Public Health Act, 1994. Officially titled The Newborn Screening Amendment Regulations, 2023, these regulations are crucial for ensuring that newborns receive timely and effective screening for metabolic disorders.

One of the changes involves terminology updates. The regulations replace references to the “Regional Health Services Act” with the “Provincial Health Authority Act,” reflecting a shift in the structure of health services in Saskatchewan. Similarly, “The Department of Health Act” is updated to “The Health Administration Act.”

Another significant addition is the definition of “physician assistant” as outlined in The Medical Profession Act, 1981, which clarifies their role in working under the supervision of a physician. Additionally, the term “practitioner” is expanded to include midwives, nurse practitioners, and physician assistants, acknowledging the diverse professionals involved in newborn care.

The amendments also emphasize the responsibilities of local authorities in managing newborn screening programs. The term “local” replaces “regional” in multiple sections, reinforcing a community-focused approach. Local authorities are now required to designate a person responsible for the newborn screening program, ensuring accountability at the community level. When a local authority identifies a newborn who has not undergone blood screening, it must take reasonable steps to address this oversight, ensuring that all newborns in their jurisdiction receive necessary screenings to identify treatable conditions that might otherwise go unnoticed.

Furthermore, if a laboratory discovers that a newborn has not been tested, it is obligated to inform the designated person in the local authority. This system ensures that any gaps in testing are quickly addressed, which is vital for early diagnosis and treatment. The regulations also include a standardized refusal form for parents who choose not to participate in newborn screening. This form outlines the implications of refusing testing, including the risks of undiagnosed conditions that could lead to severe health issues, and emphasizes that the decision should be made in consultation with a healthcare practitioner.

Newborn screening is critical for the early detection of various metabolic disorders. Conditions like phenylketonuria (PKU) and congenital hypothyroidism, if left untreated, can lead to significant health complications, including irreversible organ damage or even death. The changes outlined in these regulations aim to improve health outcomes for newborns by ensuring that screening is accessible and systematic.

Saskatchewan (54/2023) July 14, 2023